Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase III Randomized Trial for High-risk Asymptomatic or Minimally Symptomatic Bone Metastases: Early Radiotherapy Versus Observation

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07146074
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:37.484731+00:00
Published At
2026-01-20T00:00:00+00:00
Record Updated At
2026-01-20
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Solid Neoplasms", "Bone Metastases", "Asymptomatic or Minimally Symptomatic", "High Risk for Skeletal Events"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-01-20"
protocolSection.identificationModule.nctId
"NCT07146074"
protocolSection.identificationModule.officialTitle
"Phase III Randomized Trial for High-risk Asymptomatic or Minimally Symptomatic Bone Metastases: Early Radiotherapy Versus Observation"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Solid Neoplasms (protocolSection.conditionsModule.conditions)
  • Bone Metastases (protocolSection.conditionsModule.conditions)
  • Asymptomatic or Minimally Symptomatic (protocolSection.conditionsModule.conditions)
  • High Risk for Skeletal Events (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.